AI & Wearables in Pharma: How Real-Time Patient Insights Change Clinical Trials

In this episode, Marco Benítez, CEO of ROOK, talks with Dr. Andrée Bates about how AI and real-time biometric data from wearables are changing clinical trials, remote monitoring, and digital health. They cover benefits for pharmaceutical companies, CROs, and healthcare providers, case examples in oncology, vaccines, diabetes, and cardiac care, data privacy and ethics, and emerging sensors such as CGMs and wearable rings.

• How AI and wearable data are reshaping the future of clinical research
• The role of real-time biometric monitoring in early intervention and patient safety
• How the ROOK API connects 72 data sources and more than 500 devices for health data integration
• Key benefits for pharmaceutical companies, CROs, and healthcare providers
• Real-world case studies in oncology, vaccines, diabetes, and cardiac care
• Insights into data privacy (HIPAA/GDPR), security, and ethical considerations
• The future of personalized medicine, preventive care, and remote diagnostics
• Emerging technologies like CGMs, wearable rings, and even ingestible sensors

Wearable data supports research and monitoring, but it does not replace clinical judgment or validated medical devices. For more on this topic, read AI and wearable data for pharma and wearables in clinical trials.

To start working with standardized wearable data, read the ROOK API documentation.

Previous episode: How ROOK is creating a universal language for health tech